RESUMEN
OBJECTIVE: The aim of this study is to explore the prevalence of swallowing difficulties (SWD) and their associations with nutritional status, eating habits, nutritional care, and mortality among older people in assisted living. DESIGN: A cross-sectional study with interviews and nutritional assessments at baseline and 3-year follow-up for mortality. SETTING: Assisted living facilities in the Helsinki metropolitan area, Finland. PARTICIPANTS: All residents (N=1466) in assisted living facilities. MEASUREMENTS: Personal interviews yielded information on demographics, medical history, functional status, SWDs and eating habits. Residents' nutritional status was assessed with the Mini Nutritional Assessment (MNA). Three-year mortality data were retrieved from central registers. RESULTS: SWDs were common; 11.8% of subjects suffered from them. Those with SWDs were older, more often female, and more frequently had Parkinson's disease, chronic obstructive pulmonary disease (COPD), and chronic/ recurrent infections than those without SWDs. No differences were present between the groups in prevalence of stroke or dementia, but more severe cognitive decline occurred among those with SWDs. According to the MNA, 30.6% of those with SWDs were malnourished (<17 points), whereas the respective figure for those without SWDs was 11.0% (p < .001). Those with SWDs ate more often fluid or puréed food (27.8% vs. 3.8%, p < .001), ate more often little or quite little of their food portion (32.6% vs. 23.5%, p < .010), and consumed less fluids (< 5 cups/day 51.7% vs. 35.6%, p< .001) than those without SWDs. Of those with SWDs, 55.0% died by the end of follow-up, whereas the respective figure for those without SWDs was 41.5%. In logistic regression analysis using age, sex, comorbidities, and MNA as covariates, SWDs continued to predict mortality (OR=1.49, 95% CI=1.04 -2.12). CONCLUSIONS: SWDs are common and associated with poor nutrition and risk of death of patients in assisted living facilities. Nurses should be trained to assess SWDs and nutritional problems in order to take optimal care of these residents.
Asunto(s)
Instituciones de Vida Asistida , Cuidadores , Trastornos de Deglución/epidemiología , Hogares para Ancianos , Desnutrición/epidemiología , Casas de Salud , Anciano , Anciano de 80 o más Años , Comorbilidad , Estudios Transversales , Demencia/epidemiología , Conducta Alimentaria , Femenino , Finlandia/epidemiología , Estudios de Seguimiento , Humanos , Masculino , Evaluación Nutricional , Estado Nutricional , Enfermedad de Parkinson/epidemiología , Prevalencia , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Accidente Cerebrovascular/epidemiologíaRESUMEN
OBJECTIVE: Polymyositis and dermatomyositis are idiopathic, inflammatory myopathies characterized by proximal muscle fatigue. Conventional immunosuppressive treatment gives a variable response. Biopsies from chronic patients display a low proportion type I and a high proportion of type II muscle fibres. This raised a suspicion that the low proportion of type I fibres might play a role in the muscle fatigue. AIM: To investigate whether the muscle fibre attributes evident in chronic myositis are characteristic for the polymyositis and dermatomyosistis diseases themselves. METHODS: Muscle biopsies were obtained from thigh muscle from untreated patients (n = 18), treated responders (n = 14) and non-responders (n = 6) and from healthy controls (n = 11), respectively. For clinical evaluations, creatine kinase, functional index of myositis and cumulative dose of cortisone were established. RESULTS: Chronic patients had a lower proportion of type I fibres and a higher proportion of type II fibres compared to untreated myositis patients and healthy controls. Fibre cross-sectional area (CSA) did not differ between patients and healthy individuals but all women had a 20% smaller type II fibre CSA compared to men. CONCLUSIONS: Untreated polymyositis and dermatomyositis patients and healthy controls have a different fibre type composition than chronic polymyositis and dermatomyositis patients. Fibre CSA did not differ between healthy controls or any of the patient groups. A low proportion of oxidative muscle fibres can therefore be excluded as a contributing factor causing muscle fatigue at disease onset and the gender difference should be taken into consideration when evaluating fibre CSA in myositis.
Asunto(s)
Dermatomiositis/patología , Fibras Musculares de Contracción Rápida/patología , Fibras Musculares de Contracción Lenta/patología , Polimiositis/patología , Biopsia/métodos , Estudios de Casos y Controles , Enfermedad Crónica , Creatina Quinasa/sangre , Dermatomiositis/tratamiento farmacológico , Dermatomiositis/enzimología , Femenino , Glucocorticoides/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Pacientes , Polimiositis/tratamiento farmacológico , Polimiositis/enzimología , Prednisolona/uso terapéuticoRESUMEN
The production of cytokines from T cells and macrophages is of potential importance for the histological changes apparent in coeliac disease (CoD). Small intestinal biopsy specimens from children with CoD and disease control subjects were investigated for their content of cytokines and tissue transglutaminase (tTG). The transforming growth factor-beta1 (TGF-beta1) expression was increased in the lamina propria of children with villous atrophy. In contrast, TGF-beta3 was expressed at a higher level in the epithelium and the lamina propria of the disease control subjects. The tTG expression was increased in the small intestine of CoD patients as compared with that in subjects. Interleukin-4 (IL-4) was detected in the lamina propria of both CoD patients and controls, and some of the investigated biopsy specimens also showed IL-4 expression in the epithelium. We conclude that children with active CoD could have an altered expression of TGF-beta and tTG in the small intestine and that a disturbed regulation of TGF-beta may be of importance in the immune pathogenesis of CoD.
Asunto(s)
Enfermedad Celíaca/enzimología , Enfermedad Celíaca/inmunología , Proteínas de Unión al GTP/biosíntesis , Intestino Delgado/enzimología , Intestino Delgado/inmunología , Factor de Crecimiento Transformador beta/biosíntesis , Transglutaminasas/biosíntesis , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/patología , Estudios de Casos y Controles , Enfermedad Celíaca/etiología , Enfermedad Celíaca/patología , Niño , Preescolar , Epitelio/enzimología , Epitelio/inmunología , Epitelio/patología , Femenino , Humanos , Inmunohistoquímica , Interleucina-4/biosíntesis , Mucosa Intestinal/enzimología , Mucosa Intestinal/inmunología , Mucosa Intestinal/patología , Intestino Delgado/patología , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/patología , Masculino , Proteína Glutamina Gamma Glutamiltransferasa 2 , Factor de Crecimiento Transformador beta1 , Factor de Crecimiento Transformador beta3RESUMEN
The aim of our study was to address the question of whether muscle fibers express major histocompatibility complex (MHC) class II in inflammatory myopathies. For this purpose we performed a systematic study of MHC class II antigen expression on muscle fiber membranes in muscle tissue from polymyositis and dermatomyositis patients in various stages of disease activity. Thirty-two patients with classical clinical signs of myositis were divided into subgroups depending on duration of clinical signs of myositis and presence or absence of inflammatory infiltrates in muscle tissue. Immunohistochemistry as well as double-immunofluorescence stainings were used to identify the presence of MHC class II in muscle tissue. MHC class I was included for comparison. Quantification of positive staining was performed using an image analysis system in addition to evaluation by manual microscopic scoring and laser confocal microscopy. It was demonstrated that a significant proportion of skeletal muscle fibers in inflammatory myopathies express MHC class II as well as MHC class I and that MHC antigen expression is independent of the inflammatory cell infiltration. Furthermore, there were no differences in staining pattern between polymyositis and dermatomyositis patients. Our results indicate that MHC class II and MHC class I molecules may be involved in initiating and maintaining the pathological condition in myositis rather than only being a consequence of a preceding local inflammation.
Asunto(s)
Dermatomiositis/metabolismo , Antígenos de Histocompatibilidad Clase II/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/metabolismo , Polimiositis/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Dermatomiositis/patología , Dermatomiositis/fisiopatología , Femenino , Técnica del Anticuerpo Fluorescente , Antígenos de Histocompatibilidad Clase I/metabolismo , Humanos , Inmunohistoquímica , Masculino , Microscopía Confocal , Persona de Mediana Edad , Músculo Esquelético/patología , Enfermedades Musculares/metabolismo , Enfermedades Musculares/patología , Enfermedades del Sistema Nervioso/metabolismo , Enfermedades del Sistema Nervioso/patología , Polimiositis/patología , Polimiositis/fisiopatología , Índice de Severidad de la EnfermedadRESUMEN
We have investigated the inflammatory cell infiltrates and adhesion molecule expression in the synovial fluid (SF) and synovial membranes (SM) of rats with homologous collagen-induced arthritis. Immunohistochemical staining revealed that the majority of the cells in the SF were granulocytes, expressing CD11b and CD11c. In SM, the majority of the cells were monocytes/macrophages. CD49d and CD49f were expressed mainly in the erosion zone in SM, and ICAM-1 was expressed in the lining layer, in the capillaries, and in the erosion zone. In SF 7% of the cells were ICAM-1 positive. CD2 was more abundant in SM than in SF. These findings might explain the difference in granulocyte counts between SF and SM. CD49d and CD49f expression might retain lymphocytes and monocytes in SM, while granulocytes not expressing CD49d and CD49f are not retained.
Asunto(s)
Artritis Reumatoide/etiología , Artritis Reumatoide/inmunología , Moléculas de Adhesión Celular/metabolismo , Colágeno/inmunología , Animales , Antígenos de Superficie/metabolismo , Artritis Reumatoide/patología , Modelos Animales de Enfermedad , Femenino , Inmunohistoquímica , Integrina alfa4beta1 , Integrina alfa6beta1 , Integrinas/metabolismo , Macrófagos/inmunología , Monocitos/inmunología , Ratas , Receptores Mensajeros de Linfocitos/metabolismo , Líquido Sinovial/inmunología , Membrana Sinovial/inmunología , Membrana Sinovial/patología , Linfocitos T/inmunologíaRESUMEN
The kinetics of cytokine production in arthritic limbs of mice with CIA was determined by using modified immunohistochemical techniques. Tissue cryostat sections of undecalcified whole paws were analysed for the presence of tumour necrosis factor-alpha (TNF-alpha), IL-6, IL-2, IL-4, IL-5 interferon-gamma (IFN-gamma), transforming growth factor-beta 2 (TGF-beta2) and TGF-beta3. Locally produced TNF-alpha, IL-6 and TGF-beta2 were observed within the lining layer, sublining and pannus at all stages of disease. The staining of TNF-alpha was particularly intense at the cartilage-pannus junction. In contrast to the monokines, IFN-gamma and TGF-beta3 were only expressed in scattered cells within the deeper layers of the synovia. Interestingly, IFN-gamma was not present in the late phase of CIA, despite the continued presence of TNF-alpha and IL-6 in the pannus. Production of IL-2, IL-4 or IL-5 was not detected in any joint. The observed pattern of a relative paucity of T cell-derived cytokines and an abundance of monokines during the late phase of T cell-dependent CIA indicates that the synovial cytokine pattern previously described in rheumatoid arthritis (RA) is fully compatible with a pathogenic role of T cells. The temporal as well as spatial dissociation between expression of T cell-derived cytokines and monokines indicates that T cell-independent mechanisms may also be of importance in the triggering of monokine production during arthritis.